Immunomodulation of invasive fungal infections
- 1 March 2003
- journal article
- review article
- Published by Elsevier in Infectious Disease Clinics of North America
- Vol. 17 (1) , 193-219
- https://doi.org/10.1016/s0891-5520(02)00070-3
Abstract
No abstract availableKeywords
This publication has 123 references indexed in Scilit:
- Influence of Host Genetics on the Severity of CoccidioidomycosisEmerging Infectious Diseases, 1999
- Cost Effectiveness of Amphotericin B plus G-CSF Compared with Amphotericin B MonotherapyPharmacoEconomics, 1999
- Clinical Resolution of Scedosporium prolificans Fungemia Associated with Reversal of Neutropenia Following Administration of Granulocyte Colony-Stimulating FactorClinical Infectious Diseases, 1996
- Consensus on the clinical use of myeloid growth factorsCurrent Opinion in Hematology, 1996
- Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Protection of human polymorphonuclear leukocyte function from the deleterious effects of isolation, irradiation, and storage by interferon‐γ and granulocyte‐colony‐stimulating factorTransfusion, 1995
- Erythropoietin for the Treatment of Porphyria Cutanea Tarda in a Patient on Long-Term HemodialysisNew England Journal of Medicine, 1990
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon GammaNew England Journal of Medicine, 1988
- Lethal Pulmonary Reactions Associated with the Combined Use of Amphotericin B and Leukocyte TransfusionsNew England Journal of Medicine, 1981